Healthcare -
Biotechnology - NASDAQ - US
$ 35.59
4 %
$ 4.29 B
Market Cap
-11.86
P/E
RNA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RNA - Avidity Biosciences, Inc.
1.19 B
LAST VALUE
85.59%
2 YEAR CAGR
67.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR